FDA Approves Oral Treatment for Spinal Muscular Atrophy | FDA News
For Immediate Release: August 07, 2020 The U.S. Food and Drug Administration today approved Evrysdi (risdiplam) to treat patients two months of age and older with spinal muscular atrophy (SMA),…